111 related articles for article (PubMed ID: 1957898)
1. Bone marrow transplant retinopathy.
Lopez PF; Sternberg P; Dabbs CK; Vogler WR; Crocker I; Kalin NS
Am J Ophthalmol; 1991 Dec; 112(6):635-46. PubMed ID: 1957898
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
Geller RB; Myers S; Devine S; Larson RA; Williams SF; Park CL; O'Toole K; Chandler C; Topper RL
Bone Marrow Transplant; 1992 Jan; 9(1):41-7. PubMed ID: 1543948
[TBL] [Abstract][Full Text] [Related]
3. Occlusive microvascular retinopathy with optic disc and retinal neovascularization in acute lymphocytic leukemia.
Wiznia RA; Rose A; Levy AL
Retina; 1994; 14(3):253-5. PubMed ID: 7973121
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
[TBL] [Abstract][Full Text] [Related]
5. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
6. Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults.
Arai Y; Kondo T; Shigematsu A; Tanaka J; Ohashi K; Fukuda T; Kawakita T; Mori T; Hoshino T; Onizuka M; Ozawa Y; Yoshida S; Ueda Y; Mizuno I; Atsuta Y; Mizuta S;
Br J Haematol; 2017 Jul; 178(1):106-111. PubMed ID: 28439877
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
Vogler WR; Winton EF; Heffner LT; Gordon DS; Sternberg P; Crocker I; Reynolds R; Dobbs CK
Bone Marrow Transplant; 1990 Dec; 6(6):405-9. PubMed ID: 2097009
[TBL] [Abstract][Full Text] [Related]
9. [Bone marrow transplantation in the treatment of acute leukemias].
Moiseev SI; Ganapiev AA; Abdulkadyrov KM
Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
11. [Whole body irradiation before bone marrow transplantation].
Jorge L; Pereira ME; de Matos H; Patrício MB
Acta Med Port; 1990; 3(6):337-40. PubMed ID: 2089854
[TBL] [Abstract][Full Text] [Related]
12. Rare retinal complications of bone marrow transplantation (BMT): a case report.
Butt F; McKibbin M
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):225. PubMed ID: 30255790
[TBL] [Abstract][Full Text] [Related]
13. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
Stein AS; O'Donnell MR; Chai A; Schmidt GM; Nademanee A; Parker PM; Smith EP; Snyder DS; Molina A; Stepan DE; Spielberger R; Somlo G; Margolin KA; Vora N; Lipsett J; Lee J; Niland J; Forman SJ
J Clin Oncol; 1996 Aug; 14(8):2206-16. PubMed ID: 8708709
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
Kato K; Yoshida N; Matsumoto K; Matsuyama T
Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
van Besien K; Tabocoff J; Rodriguez M; Andersson B; Mehra R; Przepiorka D; Dimopoulos M; Giralt S; Suki S; Khouri I
Bone Marrow Transplant; 1995 Apr; 15(4):549-55. PubMed ID: 7655380
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic bone marrow transplantation for acute leukemia in adults.
Masszi T; Reményi P; Kriván G; Goda V; Réti M
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S77-9. PubMed ID: 9916643
[TBL] [Abstract][Full Text] [Related]
17. Effects of bone marrow transplantation on myocardial function in children.
Pihkala J; Saarinen UM; Lundström U; Salmo M; Virkola K; Virtanen K; Siimes MA; Pesonen E
Bone Marrow Transplant; 1994 Feb; 13(2):149-55. PubMed ID: 8205083
[TBL] [Abstract][Full Text] [Related]
18. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.
Katsanis E; Shapiro RS; Robison LL; Haake RJ; Kim T; Pescovitz OH; Ramsay NK
Bone Marrow Transplant; 1990 May; 5(5):335-40. PubMed ID: 2350628
[TBL] [Abstract][Full Text] [Related]
19. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J
Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens.
Woods WG; Ramsay NK; Weisdorf DJ; Haake R; Vallera DA; Kim TH; Lasky L; Nesbit ME; Bostrom B; Uckun F
Bone Marrow Transplant; 1990 Jul; 6(1):9-16. PubMed ID: 2202462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
